Lachlan Star Limited Stocks

A$ 0.18Last Updated 30.04.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

A$ 36.50M

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
A$ 0.18
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Lachlan Star Limited, together with its subsidiaries, engages in the exploration of mineral properties in Australia. It explores for gold, silver, copper, nickel, cobalt, lead, zinc, and PGE deposits. The company holds 100% interests in the Princhester Magnesite project that includes two granted mining leases located to the northwest of Rockhampton, Queensland; and the Killaloe gold project consists of two contiguous exploration licenses and the separate Buldania mining license covering an area of approximately 94 square kilometers located in the Eastern Goldfields, Western Australia. It also holds 75% interest in the Koojan project located in the New Norcia region, Western Australia. The company was formerly known as Toodyay Resources Limited and changed its name to Lachlan Star Limited in November 2007. Lachlan Star Limited was incorporated in 1970 and is based in West Perth, Australia.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks